<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35059816</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>23</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>23</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1432-1459</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>269</Volume>
            <Issue>6</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>Journal of neurology</Title>
          <ISOAbbreviation>J Neurol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Emerging technologies for management of patients with amyotrophic lateral sclerosis: from telehealth to assistive robotics and neural interfaces.</ArticleTitle>
        <Pagination>
          <StartPage>2910</StartPage>
          <EndPage>2921</EndPage>
          <MedlinePgn>2910-2921</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s00415-022-10971-w</ELocationID>
        <Abstract>
          <AbstractText>Amyotrophic lateral sclerosis (ALS), also known as motor neuron disease, is characterized by the degeneration of both upper and lower motor neurons, which leads to muscle weakness and subsequently paralysis. It begins subtly with focal weakness but spreads relentlessly to involve most muscles, thus proving to be effectively incurable. Typically, death due to respiratory paralysis occurs in 3-5 years. To date, it has been shown that the management of ALS patients is best achieved with a multidisciplinary approach, and with the help of emerging technologies ranging from multidisciplinary teleconsults (for monitoring the dysphagia, respiratory function, and nutritional status) to brain-computer interfaces and eye tracking for alternative augmentative communication, until robotics, it may increase effectiveness. The COVID-19 pandemic created a spasmodic need to accelerate the development and implementation of such technologies in clinical practice, to improve the daily lives of both ALS patients and caregivers. However, despite the remarkable strides that have been made in the field, there are still issues to be addressed. This review will be discussed on the eureka moment of emerging technologies for ALS, used as a blueprint not only for neurodegenerative diseases, examining the current technologies already in place or being evaluated, highlighting the pros and cons for future clinical applications.</AbstractText>
          <CopyrightInformation>© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Pugliese</LastName>
            <ForeName>Raffaele</ForeName>
            <Initials>R</Initials>
            <Identifier Source="ORCID">0000-0001-7669-4457</Identifier>
            <AffiliationInfo>
              <Affiliation>NeMO Lab, ASST Niguarda Cà Granda Hospital, Milan, Italy. raffaele.pugliese@nemolab.it.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sala</LastName>
            <ForeName>Riccardo</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>NeMO Lab, ASST Niguarda Cà Granda Hospital, Milan, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Regondi</LastName>
            <ForeName>Stefano</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>NeMO Lab, ASST Niguarda Cà Granda Hospital, Milan, Italy.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>NEuroMuscolar Omnicentre, Milan, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Beltrami</LastName>
            <ForeName>Benedetta</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>NeMO Lab, ASST Niguarda Cà Granda Hospital, Milan, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lunetta</LastName>
            <ForeName>Christian</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>NeMO Lab, ASST Niguarda Cà Granda Hospital, Milan, Italy. chrisitan.lunetta@nemolab.it.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>NEuroMuscolar Omnicentre, Milan, Italy. chrisitan.lunetta@nemolab.it.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>01</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>J Neurol</MedlineTA>
        <NlmUniqueID>0423161</NlmUniqueID>
        <ISSNLinking>0340-5354</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName>
          <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017216" MajorTopicYN="Y">Telemedicine</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword>
        <Keyword MajorTopicYN="N">Brain-computer interface</Keyword>
        <Keyword MajorTopicYN="N">Clinical management</Keyword>
        <Keyword MajorTopicYN="N">Emerging technologies</Keyword>
        <Keyword MajorTopicYN="N">Eye tracking</Keyword>
        <Keyword MajorTopicYN="N">Internet of things</Keyword>
        <Keyword MajorTopicYN="N">Motor neuron diseases</Keyword>
        <Keyword MajorTopicYN="N">Robotics</Keyword>
        <Keyword MajorTopicYN="N">Telemedicine</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare no competing interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>12</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>11</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>24</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>21</Day>
          <Hour>6</Hour>
          <Minute>31</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35059816</ArticleId>
        <ArticleId IdType="pmc">PMC8776511</ArticleId>
        <ArticleId IdType="doi">10.1007/s00415-022-10971-w</ArticleId>
        <ArticleId IdType="pii">10.1007/s00415-022-10971-w</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Masrori P, Van Damme P. Amyotrophic lateral sclerosis: a clinical review. Eur J Neurol. 2020;27(10):1918–1929. doi: 10.1111/ene.14393.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/ene.14393</ArticleId>
            <ArticleId IdType="pmc">PMC7540334</ArticleId>
            <ArticleId IdType="pubmed">32526057</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zarei S, Carr K, Reiley L, Diaz K, Guerra O, Altamirano PF, Pagani W, Lodin D, Orozco G, Chinea A. A comprehensive review of amyotrophic lateral sclerosis. Surg Neurol Int. 2015;6:171. doi: 10.4103/2152-7806.169561.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4103/2152-7806.169561</ArticleId>
            <ArticleId IdType="pmc">PMC4653353</ArticleId>
            <ArticleId IdType="pubmed">26629397</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nguyen C, Caga J, Mahoney CJ, Kiernan MC, Huynh W. Behavioural changes predict poorer survival in amyotrophic lateral sclerosis. Brain Cogn. 2021;150:105710. doi: 10.1016/j.bandc.2021.105710.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bandc.2021.105710</ArticleId>
            <ArticleId IdType="pubmed">33725515</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brown RH, Al-Chalabi A. Amyotrophic lateral sclerosis. N Engl J Med. 2017;377(2):162–172. doi: 10.1056/NEJMra1603471.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId>
            <ArticleId IdType="pubmed">28700839</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ferrari R, Kapogiannis D, Huey ED, Momeni P. FTD and ALS: a tale of two diseases. Curr Alzheimer Res. 2011;8(3):273–294. doi: 10.2174/156720511795563700.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2174/156720511795563700</ArticleId>
            <ArticleId IdType="pmc">PMC3801195</ArticleId>
            <ArticleId IdType="pubmed">21222600</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nitrini R. Frontotemporal dementia and amyotrophic lateral sclerosis: revisiting one of the first case reports with neuropathology examination. Dement Neuropsychol. 2014;8(1):83–86. doi: 10.1590/S1980-57642014DN81000013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1590/S1980-57642014DN81000013</ArticleId>
            <ArticleId IdType="pmc">PMC5619453</ArticleId>
            <ArticleId IdType="pubmed">29213884</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Niedermeyer S, Murn M, Choi PJ. Respiratory failure in amyotrophic lateral sclerosis. Chest. 2019;155(2):401. doi: 10.1016/j.chest.2018.06.035.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.chest.2018.06.035</ArticleId>
            <ArticleId IdType="pubmed">29990478</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cluskey S, Ramsden DB. Mechanisms of neurodegeneration in amyotrophic lateral sclerosis. Mol Pathol. 2001;54(6):386–392.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1187128</ArticleId>
            <ArticleId IdType="pubmed">11724913</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barber SC, Mead RJ, Shaw PJ. Oxidative stress in ALS: a mechanism of neurodegeneration and a therapeutic target. Biochim Biophys Acta. 2006;1762(11–12):1051–1067. doi: 10.1016/j.bbadis.2006.03.008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbadis.2006.03.008</ArticleId>
            <ArticleId IdType="pubmed">16713195</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dharmadasa T, Kiernan MC. Riluzole, disease stage and survival in ALS. Lancet Neurol. 2018;17(5):385–386. doi: 10.1016/S1474-4422(18)30091-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1474-4422(18)30091-7</ArticleId>
            <ArticleId IdType="pubmed">29525493</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fang T, Al Khleifat A, Meurgey JH, Jones A, Leigh PN, Bensimon G, Al-Chalabi A. Stage at which riluzole treatment prolongs survival in patients with amyotrophic lateral sclerosis: a retrospective analysis of data from a dose-ranging study. Lancet Neurol. 2018;17(5):416–422. doi: 10.1016/S1474-4422(18)30054-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1474-4422(18)30054-1</ArticleId>
            <ArticleId IdType="pmc">PMC5899963</ArticleId>
            <ArticleId IdType="pubmed">29525492</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Breiner A, Zinman L, Bourque PR. Edaravone for amyotrophic lateral sclerosis: barriers to access and lifeboat ethics. CMAJ. 2020;192(12):E319–E320. doi: 10.1503/cmaj.191236.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1503/cmaj.191236</ArticleId>
            <ArticleId IdType="pmc">PMC7101182</ArticleId>
            <ArticleId IdType="pubmed">32392516</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rothstein JD. Edaravone: a new drug approved for ALS. Cell. 2017;171(4):725. doi: 10.1016/j.cell.2017.10.011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2017.10.011</ArticleId>
            <ArticleId IdType="pubmed">29100067</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dorst J, Ludolph AC. Non-invasive ventilation in amyotrophic lateral sclerosis. Ther Adv Neurol Disord. 2019;12:1756286419857040. doi: 10.1177/1756286419857040.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/1756286419857040</ArticleId>
            <ArticleId IdType="pmc">PMC6589990</ArticleId>
            <ArticleId IdType="pubmed">31258624</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bourke SC, Gibson GJ. Non-invasive ventilation in ALS: current practice and future role. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004;5(2):67–71. doi: 10.1080/14660820410020330.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/14660820410020330</ArticleId>
            <ArticleId IdType="pubmed">15204008</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mayadev AS, Weiss MD, Distad BJ, Krivickas LS, Carter GT. The amyotrophic lateral sclerosis center: a model of multidisciplinary management. Phys Med Rehabil Clin N Am. 2008;19(3):619–631. doi: 10.1016/j.pmr.2008.04.004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.pmr.2008.04.004</ArticleId>
            <ArticleId IdType="pubmed">18625420</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hogden A, Foley G, Henderson RD, James N, Aoun SM. Amyotrophic lateral sclerosis: improving care with a multidisciplinary approach. J Multidiscip Healthc. 2017;10:205–215. doi: 10.2147/JMDH.S134992.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2147/JMDH.S134992</ArticleId>
            <ArticleId IdType="pmc">PMC5446964</ArticleId>
            <ArticleId IdType="pubmed">28579792</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hobson EV, Baird WO, Cooper CL, Mawson S, Shaw PJ, McDermott CJ. Using technology to improve access to specialist care in amyotrophic lateral sclerosis: a systematic review. Amyotroph Lateral Scler Frontotemporal Degener. 2016;17(5–6):313–324. doi: 10.3109/21678421.2016.1165255.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3109/21678421.2016.1165255</ArticleId>
            <ArticleId IdType="pubmed">27027466</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Londral A, Pinto A, Pinto S, Azevedo L, De Carvalho M. Quality of life in amyotrophic lateral sclerosis patients and caregivers: impact of assistive communication from early stages. Muscle Nerve. 2015;52(6):933–941. doi: 10.1002/mus.24659.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/mus.24659</ArticleId>
            <ArticleId IdType="pubmed">25808635</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pinto S, Quintarelli S, Silani V. New technologies and amyotrophic lateral sclerosis—which step forward rushed by the COVID-19 pandemic? J Neurol Sci. 2020;418:117081. doi: 10.1016/j.jns.2020.117081.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jns.2020.117081</ArticleId>
            <ArticleId IdType="pmc">PMC7403097</ArticleId>
            <ArticleId IdType="pubmed">32882437</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Steinbach R, Prell T, Gaur N, Stubendorff B, Roediger A, Ilse B, Witte OW, Grosskreutz J. Triage of amyotrophic lateral sclerosis patients during the COVID-19 pandemic: an application of the D50 model. J Clin Med. 2020 doi: 10.3390/jcm9092873.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/jcm9092873</ArticleId>
            <ArticleId IdType="pmc">PMC7565659</ArticleId>
            <ArticleId IdType="pubmed">32899481</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Adner R, Levinthal DA. The emergence of emerging technologies. Calif Manag Rev. 2002;45(1):50. doi: 10.2307/41166153.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2307/41166153</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Day GS, Schoemaker PJH. Avoiding the pitfalls of emerging technologies. Calif Manag Rev. 2000;42(2):8. doi: 10.2307/41166030.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2307/41166030</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Abercrombie RK, Udoeyop AW, Schlicher BG. A study of scientometric methods to identify emerging technologies via modeling of milestones. Scientometrics. 2012;91(2):327. doi: 10.1007/s11192-011-0614-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11192-011-0614-4</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rotolo D, Hicks D, Martin BR. What is an emerging technology? Res Policy. 2015;44(10):1827. doi: 10.1016/j.respol.2015.06.006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.respol.2015.06.006</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moore M. The evolution of telemedicine. Future Gener Comput Syst. 1999;15(2):245. doi: 10.1016/S0167-739X(98)00067-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0167-739X(98)00067-3</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>A.A.o. Neurology, 2020. https://www.aan.com/tools-and-resources/practicing-neurologists-administrators/telemedicine-and-remote-care/. Accessed 13 May 2021</Citation>
        </Reference>
        <Reference>
          <Citation>Garcia-Gancedo L, Kelly ML, Lavrov A, Parr J, Hart R, Marsden R, Turner MR, Talbot K, Chiwera T, Shaw CE, Al-Chalabi A. Objectively monitoring amyotrophic lateral sclerosis patient symptoms during clinical trials with sensors: observational study. JMIR Mhealth Uhealth. 2019;7(12):e13433. doi: 10.2196/13433.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2196/13433</ArticleId>
            <ArticleId IdType="pmc">PMC6942190</ArticleId>
            <ArticleId IdType="pubmed">31859676</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Helleman J, Van Eenennaam R, Kruitwagen ET, Kruithof WJ, Slappendel MJ, Van Den Berg LH, Visser-Meily JMA, Beelen A. Telehealth as part of specialized ALS care: feasibility and user experiences with “ALS home-monitoring and coaching”. Amyotroph Lateral Scler Frontotemporal Degener. 2020;21(3–4):183–192. doi: 10.1080/21678421.2020.1718712.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/21678421.2020.1718712</ArticleId>
            <ArticleId IdType="pubmed">32003245</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Helleman J, Kruitwagen ET, van den Berg LH, Visser-Meily JMA, Beelen A. The current use of telehealth in ALS care and the barriers to and facilitators of implementation: a systematic review. Amyotroph Lateral Scler Frontotemporal Degener. 2020;21(3–4):167–182. doi: 10.1080/21678421.2019.1706581.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/21678421.2019.1706581</ArticleId>
            <ArticleId IdType="pubmed">31878794</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vasta R, Moglia C, D'Ovidio F, Di Pede F, De Mattei F, Cabras S, Peotta L, Iazzolino B, Giusiano S, Manera U, Palumbo F, Bombaci A, Torrieri MC, Ilardi A, Mastro E, Arcari M, Solero L, Grassano M, Daviddi M, Matteoni E, Salamone P, Fuda G, Canosa A, Chio A, Calvo A. Telemedicine for patients with amyotrophic lateral sclerosis during COVID-19 pandemic: an Italian ALS referral center experience. Amyotroph Lateral Scler Frontotemporal Degener. 2020 doi: 10.1080/21678421.2020.1820043.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/21678421.2020.1820043</ArticleId>
            <ArticleId IdType="pubmed">32924624</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bombaci A, Abbadessa G, Trojsi F, Leocani L, Bonavita S, Lavorgna L, W. Digital Technologies, N. Social Media Study Group of the Italian Society of  Telemedicine for management of patients with amyotrophic lateral sclerosis through COVID-19 tail. Neurol Sci. 2021;42(1):9–13. doi: 10.1007/s10072-020-04783-x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10072-020-04783-x</ArticleId>
            <ArticleId IdType="pmc">PMC7538170</ArticleId>
            <ArticleId IdType="pubmed">33025327</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Geronimo A, Wright C, Morris A, Walsh S, Snyder B, Simmons Z. Incorporation of telehealth into a multidisciplinary ALS Clinic: feasibility and acceptability. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18(7–8):555–561. doi: 10.1080/21678421.2017.1338298.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/21678421.2017.1338298</ArticleId>
            <ArticleId IdType="pubmed">28678542</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Govindarajan R, Berry JD, Paganoni S, Pulley MT, Simmons Z. Optimizing telemedicine to facilitate amyotrophic lateral sclerosis clinical trials. Muscle Nerve. 2020;62(3):321–326. doi: 10.1002/mus.26921.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/mus.26921</ArticleId>
            <ArticleId IdType="pubmed">32415876</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wills AM, Garry J, Hubbard J, Mezoian T, Breen CT, Ortiz-Miller C, Nalipinski P, Sullivan S, Berry JD, Cudkowicz M, Paganoni S, Chan J, Macklin EA. Nutritional counseling with or without mobile health technology: a randomized open-label standard-of-care-controlled trial in ALS. BMC Neurol. 2019;19(1):104. doi: 10.1186/s12883-019-1330-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12883-019-1330-6</ArticleId>
            <ArticleId IdType="pmc">PMC6540456</ArticleId>
            <ArticleId IdType="pubmed">31142272</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vitacca M, Comini L, Tentorio M, Assoni G, Trainini D, Fiorenza D, Morini R, Bruletti G, Scalvini S. A pilot trial of telemedicine-assisted, integrated care for patients with advanced amyotrophic lateral sclerosis and their caregivers. J Telemed Telecare. 2010;16(2):83–88. doi: 10.1258/jtt.2009.090604.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1258/jtt.2009.090604</ArticleId>
            <ArticleId IdType="pubmed">20139136</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brearly TW, Shura RD, Martindale SL, Lazowski RA, Luxton DD, Shenal BV, Rowland JA. Neuropsychological test administration by videoconference: a systematic review and meta-analysis. Neuropsychol Rev. 2017;27(2):174–186. doi: 10.1007/s11065-017-9349-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11065-017-9349-1</ArticleId>
            <ArticleId IdType="pubmed">28623461</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Linse K, Aust E, Joos M, Hermann A. Communication matters-pitfalls and promise of hightech communication devices in palliative care of severely physically disabled patients with amyotrophic lateral sclerosis. Front Neurol. 2018;9:603. doi: 10.3389/fneur.2018.00603.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fneur.2018.00603</ArticleId>
            <ArticleId IdType="pmc">PMC6072854</ArticleId>
            <ArticleId IdType="pubmed">30100896</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pasqualotto E, Matuz T, Federici S, Ruf CA, Bartl M, Olivetti Belardinelli M, Birbaumer N, Halder S. Usability and workload of access technology for people with severe motor impairment: a comparison of brain-computer interfacing and eye tracking. Neurorehabil Neural Repair. 2015;29(10):950–957. doi: 10.1177/1545968315575611.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/1545968315575611</ArticleId>
            <ArticleId IdType="pubmed">25753951</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang C, Guan C, Zhang H. P300 brain-computer interface design for communication and control applications. Conf Proc IEEE Eng Med Biol Soc. 2005;2005:5400–5403. doi: 10.1109/IEMBS.2005.1615703.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1109/IEMBS.2005.1615703</ArticleId>
            <ArticleId IdType="pubmed">17281473</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pfurtscheller G, Neuper C, Schlogl A, Lugger K. Separability of EEG signals recorded during right and left motor imagery using adaptive autoregressive parameters. IEEE Trans Rehabil Eng. 1998;6(3):316–325. doi: 10.1109/86.712230.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1109/86.712230</ArticleId>
            <ArticleId IdType="pubmed">9749909</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wolpaw JR, Birbaumer N, Heetderks WJ, McFarland DJ, Peckham PH, Schalk G, Donchin E, Quatrano LA, Robinson CJ, Vaughan TM. Brain-computer interface technology: a review of the first international meeting. IEEE Trans Rehabil Eng. 2000;8(2):164–173. doi: 10.1109/tre.2000.847807.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1109/tre.2000.847807</ArticleId>
            <ArticleId IdType="pubmed">10896178</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wolpaw JR, Birbaumer N, McFarland DJ, Pfurtscheller G, Vaughan TM. Brain-computer interfaces for communication and control. Clin Neurophysiol. 2002;113(6):767–791. doi: 10.1016/s1388-2457(02)00057-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s1388-2457(02)00057-3</ArticleId>
            <ArticleId IdType="pubmed">12048038</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cipresso P, Carelli L, Solca F, Meazzi D, Meriggi P, Poletti B, Lule D, Ludolph AC, Silani V, Riva G. The use of P300-based BCIs in amyotrophic lateral sclerosis: from augmentative and alternative communication to cognitive assessment. Brain Behav. 2012;2(4):479–498. doi: 10.1002/brb3.57.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/brb3.57</ArticleId>
            <ArticleId IdType="pmc">PMC3432970</ArticleId>
            <ArticleId IdType="pubmed">22950051</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nijboer F, Sellers EW, Mellinger J, Jordan MA, Matuz T, Furdea A, Halder S, Mochty U, Krusienski DJ, Vaughan TM, Wolpaw JR, Birbaumer N, Kubler A. A P300-based brain-computer interface for people with amyotrophic lateral sclerosis. Clin Neurophysiol. 2008;119(8):1909–1916. doi: 10.1016/j.clinph.2008.03.034.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.clinph.2008.03.034</ArticleId>
            <ArticleId IdType="pmc">PMC2853977</ArticleId>
            <ArticleId IdType="pubmed">18571984</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mak JN, McFarland DJ, Vaughan TM, McCane LM, Tsui PZ, Zeitlin DJ, Sellers EW, Wolpaw JR. EEG correlates of P300-based brain-computer interface (BCI) performance in people with amyotrophic lateral sclerosis. J Neural Eng. 2012;9(2):026014. doi: 10.1088/1741-2560/9/2/026014.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1088/1741-2560/9/2/026014</ArticleId>
            <ArticleId IdType="pubmed">22350501</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guy V, Soriani MH, Bruno M, Papadopoulo T, Desnuelle C, Clerc M. Brain computer interface with the P300 speller: usability for disabled people with amyotrophic lateral sclerosis. Ann Phys Rehabil Med. 2018;61(1):5–11. doi: 10.1016/j.rehab.2017.09.004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.rehab.2017.09.004</ArticleId>
            <ArticleId IdType="pubmed">29024794</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Medina-Julia MT, Fernandez-Rodriguez A, Velasco-Alvarez F, Ron-Angevin R. P300-based brain-computer interface speller: usability evaluation of three speller sizes by severely motor-disabled patients. Front Hum Neurosci. 2020;14:583358. doi: 10.3389/fnhum.2020.583358.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fnhum.2020.583358</ArticleId>
            <ArticleId IdType="pmc">PMC7658534</ArticleId>
            <ArticleId IdType="pubmed">33192417</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Murguialday AR, Hill J, Bensch M, Martens S, Halder S, Nijboer F, Schoelkopf B, Birbaumer N, Gharabaghi A. Transition from the locked in to the completely locked-in state: a physiological analysis. Clin Neurophysiol. 2011;122(5):925–933. doi: 10.1016/j.clinph.2010.08.019.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.clinph.2010.08.019</ArticleId>
            <ArticleId IdType="pubmed">20888292</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kubler A, Neumann N, Kaiser J, Kotchoubey B, Hinterberger T, Birbaumer NP. Brain-computer communication: self-regulation of slow cortical potentials for verbal communication. Arch Phys Med Rehabil. 2001;82(11):1533–1539. doi: 10.1053/apmr.2001.26621.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1053/apmr.2001.26621</ArticleId>
            <ArticleId IdType="pubmed">11689972</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lim AK, Ryu J, Yoon HM, Yang HC, Kim SK. Ergonomic effects of medical augmented reality glasses in video-assisted surgery. Surg Endosc. 2021 doi: 10.1007/s00464-021-08363-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00464-021-08363-8</ArticleId>
            <ArticleId IdType="pubmed">34580773</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ball LJ, Beukelman DR, Pattee GL. Communication effectiveness of individuals with amyotrophic lateral sclerosis. J Commun Disord. 2004;37(3):197–215. doi: 10.1016/j.jcomdis.2003.09.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jcomdis.2003.09.002</ArticleId>
            <ArticleId IdType="pubmed">15063143</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rong P, Usler E, Rowe LM, Allison K, Woo J, El Fakhri G, Green JR. Speech intelligibility loss due to amyotrophic lateral sclerosis: the effect of tongue movement reduction on vowel and consonant acoustic features. Clin Linguist Phon. 2021 doi: 10.1080/02699206.2020.1868021.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/02699206.2020.1868021</ArticleId>
            <ArticleId IdType="pubmed">33427505</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Roth CR, Glaze LE, Goding GS, Jr, David WS. Spasmodic dysphonia symptoms as initial presentation of amyotrophic lateral sclerosis. J Voice. 1996;10(4):362–367. doi: 10.1016/s0892-1997(96)80028-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s0892-1997(96)80028-2</ArticleId>
            <ArticleId IdType="pubmed">8943140</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tomik B, Guiloff RJ. Dysarthria in amyotrophic lateral sclerosis: a review. Amyotroph Lateral Scler. 2010;11(1–2):4–15. doi: 10.3109/17482960802379004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3109/17482960802379004</ArticleId>
            <ArticleId IdType="pubmed">20184513</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Leite Neto L, Franca Junior MC, Chun RYS. Speech intelligibility in people with amyotrophic lateral sclerosis (ALS) Codas. 2021;33(1):e20190214. doi: 10.1590/2317-1782/20202019214.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1590/2317-1782/20202019214</ArticleId>
            <ArticleId IdType="pubmed">33533830</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Caligari M, Godi M, Guglielmetti S, Franchignoni F, Nardone A. Eye tracking communication devices in amyotrophic lateral sclerosis: impact on disability and quality of life. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14(7–8):546–552. doi: 10.3109/21678421.2013.803576.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3109/21678421.2013.803576</ArticleId>
            <ArticleId IdType="pubmed">23834069</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Phukan J, Elamin M, Bede P, Jordan N, Gallagher L, Byrne S, Lynch C, Pender N, Hardiman O. The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study. J Neurol Neurosurg Psychiatry. 2012;83(1):102–108. doi: 10.1136/jnnp-2011-300188.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/jnnp-2011-300188</ArticleId>
            <ArticleId IdType="pubmed">21836033</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Beeldman E, Raaphorst J, Klein Twennaar M, de Visser M, Schmand BA, de Haan RJ. The cognitive profile of ALS: a systematic review and meta-analysis update. J Neurol Neurosurg Psychiatry. 2016;87(6):611–619. doi: 10.1136/jnnp-2015-310734.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/jnnp-2015-310734</ArticleId>
            <ArticleId IdType="pubmed">26283685</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goldstein LH, Abrahams S. Changes in cognition and behaviour in amyotrophic lateral sclerosis: nature of impairment and implications for assessment. Lancet Neurol. 2013;12(4):368–380. doi: 10.1016/S1474-4422(13)70026-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1474-4422(13)70026-7</ArticleId>
            <ArticleId IdType="pubmed">23518330</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Poletti B, Carelli L, Solca F, Lafronza A, Pedroli E, Faini A, Ticozzi N, Ciammola A, Meriggi P, Cipresso P, Lule D, Ludolph AC, Riva G, Silani V. An eye-tracker controlled cognitive battery: overcoming verbal-motor limitations in ALS. J Neurol. 2017;264(6):1136–1145. doi: 10.1007/s00415-017-8506-z.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00415-017-8506-z</ArticleId>
            <ArticleId IdType="pubmed">28503706</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Poletti B, Carelli L, Faini A, Solca F, Meriggi P, Lafronza A, Ciringione L, Pedroli E, Ticozzi N, Ciammola A, Cipresso P, Riva G, Silani V. The arrows and colors cognitive test (ACCT): a new verbal-motor free cognitive measure for executive functions in ALS. PLoS ONE. 2018;13(8):e0200953. doi: 10.1371/journal.pone.0200953.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0200953</ArticleId>
            <ArticleId IdType="pmc">PMC6084851</ArticleId>
            <ArticleId IdType="pubmed">30091987</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Semprini M, Laffranchi M, Sanguineti V, Avanzino L, De Icco R, De Michieli L, Chiappalone M. Technological approaches for neurorehabilitation: from robotic devices to brain stimulation and beyond. Front Neurol. 2018;9:212. doi: 10.3389/fneur.2018.00212.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fneur.2018.00212</ArticleId>
            <ArticleId IdType="pmc">PMC5900382</ArticleId>
            <ArticleId IdType="pubmed">29686644</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Braun RG, Wittenberg GF. Motor recovery: how rehabilitation techniques and technologies can enhance recovery and neuroplasticity. Semin Neurol. 2021 doi: 10.1055/s-0041-1725138.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1055/s-0041-1725138</ArticleId>
            <ArticleId IdType="pubmed">33663001</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Major ZZ, Vaida C, Major KA, Tucan P, Simori G, Banica A, Brusturean E, Burz A, Craciunas R, Ulinici I, Carbone G, Gherman B, Birlescu I, Pisla D. The impact of robotic rehabilitation on the motor system in neurological diseases. A multimodal neurophysiological approach. Int J Environ Res Public Health. 2020 doi: 10.3390/ijerph17186557.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijerph17186557</ArticleId>
            <ArticleId IdType="pmc">PMC7557539</ArticleId>
            <ArticleId IdType="pubmed">32916890</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Simmatis L, Atallah G, Scott SH, Taylor S. The feasibility of using robotic technology to quantify sensory, motor, and cognitive impairments associated with ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2019;20(1–2):43–52. doi: 10.1080/21678421.2018.1550515.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/21678421.2018.1550515</ArticleId>
            <ArticleId IdType="pubmed">30688092</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mostafavi SM, Dukelow SP, Glasgow JI, Scott SH, Mousavi P. Reduction of stroke assessment time for visually guided reaching task on KINARM exoskeleton robot. Annu Int Conf IEEE Eng Med Biol Soc. 2014;2014:5296–5299. doi: 10.1109/EMBC.2014.6944821.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1109/EMBC.2014.6944821</ArticleId>
            <ArticleId IdType="pubmed">25571189</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tyryshkin K, Coderre AM, Glasgow JI, Herter TM, Bagg SD, Dukelow SP, Scott SH. A robotic object hitting task to quantify sensorimotor impairments in participants with stroke. J Neuroeng Rehabil. 2014;11:47. doi: 10.1186/1743-0003-11-47.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1743-0003-11-47</ArticleId>
            <ArticleId IdType="pmc">PMC3992166</ArticleId>
            <ArticleId IdType="pubmed">24693877</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bourke TC, Lowrey CR, Dukelow SP, Bagg SD, Norman KE, Scott SH. A robot-based behavioural task to quantify impairments in rapid motor decisions and actions after stroke. J Neuroeng Rehabil. 2016;13(1):91. doi: 10.1186/s12984-016-0201-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12984-016-0201-2</ArticleId>
            <ArticleId IdType="pmc">PMC5057404</ArticleId>
            <ArticleId IdType="pubmed">27724945</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lowrey CR, Jackson CPT, Bagg SD, Dukelow SP, Scott SH. A novel robotic task for assessing impairments in bimanual coordination post-stroke. Int J Phys Med Rehab. 2014;10(1):10.</Citation>
        </Reference>
        <Reference>
          <Citation>Centen A, Lowrey CR, Scott SH, Yeh TT, Mochizuki G. KAPS (kinematic assessment of passive stretch): a tool to assess elbow flexor and extensor spasticity after stroke using a robotic exoskeleton. J Neuroeng Rehabil. 2017;14(1):59. doi: 10.1186/s12984-017-0272-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12984-017-0272-8</ArticleId>
            <ArticleId IdType="pmc">PMC5477344</ArticleId>
            <ArticleId IdType="pubmed">28629415</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dukelow SP, Herter TM, Moore KD, Demers MJ, Glasgow JI, Bagg SD, Norman KE, Scott SH. Quantitative assessment of limb position sense following stroke. Neurorehabil Neural Repair. 2010;24(2):178–187. doi: 10.1177/1545968309345267.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/1545968309345267</ArticleId>
            <ArticleId IdType="pubmed">19794134</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Little CE, Emery C, Black A, Scott SH, Meeuwisse W, Nettel-Aguirre A, Benson B, Dukelow S. Test-retest reliability of KINARM robot sensorimotor and cognitive assessment: in pediatric ice hockey players. J Neuroeng Rehabil. 2015;12:78. doi: 10.1186/s12984-015-0070-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12984-015-0070-0</ArticleId>
            <ArticleId IdType="pmc">PMC4560901</ArticleId>
            <ArticleId IdType="pubmed">26341424</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Portaro S, Cimino V, Accorinti M, Pidala A, Naro A, Calabro RS. A promising tool for flail arm in amyotrophic lateral sclerosis rehabilitation: a case report. Eur J Phys Rehabil Med. 2019;55(4):515–518. doi: 10.23736/S1973-9087.18.05249-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.23736/S1973-9087.18.05249-8</ArticleId>
            <ArticleId IdType="pubmed">29904049</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bonanno L, Russo M, Bramanti A, Calabro RS, Marino S. Functional connectivity in multiple sclerosis after robotic rehabilitative treatment: a case report. Medicine (Baltimore) 2019;98(17):e15047. doi: 10.1097/MD.0000000000015047.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MD.0000000000015047</ArticleId>
            <ArticleId IdType="pmc">PMC6831415</ArticleId>
            <ArticleId IdType="pubmed">31027053</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Casadio M, Sanguineti V. Learning, retention, and slacking: a model of the dynamics of recovery in robot therapy. IEEE Trans Neural Syst Rehabil Eng. 2012;20(3):286–296. doi: 10.1109/TNSRE.2012.2190827.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1109/TNSRE.2012.2190827</ArticleId>
            <ArticleId IdType="pubmed">22531822</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Reinkensmeyer DJ, Burdet E, Casadio M, Krakauer JW, Kwakkel G, Lang CE, Swinnen SP, Ward NS, Schweighofer N. Computational neurorehabilitation: modeling plasticity and learning to predict recovery. J Neuroeng Rehabil. 2016;13(1):42. doi: 10.1186/s12984-016-0148-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12984-016-0148-3</ArticleId>
            <ArticleId IdType="pmc">PMC4851823</ArticleId>
            <ArticleId IdType="pubmed">27130577</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Choi YS, Deyle T, Kemp CC (2009) A list of household objects for robotic retrieval prioritized by people with ALS. Robotics. arXiv:0902.2186</Citation>
        </Reference>
        <Reference>
          <Citation>King CH, Chen TL, Fan Z, Glass JD, Kemp CC. Dusty: an assistive mobile manipulator that retrieves dropped objects for people with motor impairments. Disabil Rehabil Assist Technol. 2012;7(2):168–179. doi: 10.3109/17483107.2011.615374.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3109/17483107.2011.615374</ArticleId>
            <ArticleId IdType="pmc">PMC3296521</ArticleId>
            <ArticleId IdType="pubmed">22013888</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Parre MD, Sujatha B. Novel human-centered robotics: towards an automated process for neurorehabilitation. Neurol Res Int. 2021;2021:6690715. doi: 10.1155/2021/6690715.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2021/6690715</ArticleId>
            <ArticleId IdType="pmc">PMC7867438</ArticleId>
            <ArticleId IdType="pubmed">33564477</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yamamoto T, Terada K, Ochiai A, Saito F, Asahara Y, Murase K. Development of human support robot as the research platform of a domestic mobile manipulator. ROBOMECH J. 2019;6:3. doi: 10.1186/s40648-019-0131-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s40648-019-0131-4</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
